Michael King
Stock Analyst at Rodman & Renshaw
(0.64)
# 4,043
Out of 4,574 analysts
345
Total ratings
38.6%
Success rate
-1.9%
Average return
Main Sectors:
Stocks Rated by Michael King
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZNTL Zentalis Pharmaceuticals | Initiated Coverage: Buy | $11 | $4.33 | +154.04% | 1 | Jul 23, 2026 | |
| ATOS Atossa Therapeutics | Initiated Coverage: Buy | $12 | $2.30 | +422.88% | 1 | Jul 7, 2026 | |
| VTVT vTv Therapeutics | Initiated Coverage: Buy | $67 | $30.73 | +118.03% | 1 | Jun 30, 2026 | |
| KYNB Kyntra Bio | Initiated Coverage: Buy | $30 | $7.03 | +326.74% | 1 | Jun 9, 2026 | |
| BOLT Bolt Biotherapeutics | Initiated Coverage: Buy | $22 | $3.83 | +474.41% | 1 | May 28, 2026 | |
| SANA Sana Biotechnology | Initiated Coverage: Buy | $16 | $3.18 | +403.14% | 1 | May 11, 2026 | |
| HURA TuHURA Biosciences | Initiated Coverage: Buy | $150 → $7 | $2.11 | +231.75% | 7 | Apr 15, 2026 | |
| BTAI BioXcel Therapeutics | Initiated Coverage: Buy | $17 | $0.8475 | +1,905.90% | 1 | Mar 17, 2026 | |
| KPTI Karyopharm Therapeutics | Initiated Coverage: Buy | $22 → $28 | $7.41 | +277.87% | 8 | Mar 9, 2026 | |
| ELTX Elicio Therapeutics | Initiated Coverage: Buy | $17 | $3.00 | +466.67% | 1 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $100 | $5.16 | +1,837.98% | 1 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $69 → $17 | $0.6884 | +2,369.49% | 10 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $200 | $3.37 | +5,834.72% | 1 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 → $8 | $1.25 | +540.00% | 12 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.8818 | +807.24% | 1 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.15 | +595.65% | 1 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $2.75 | n/a | 17 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $5.26 | n/a | 5 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $862 | $656.01 | n/a | 40 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $55.37 | n/a | 26 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $17 | $0.0004 | n/a | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $18.21 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.3 | $5.98 | n/a | 8 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.3 | $0.427 | n/a | 17 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $19.44 | n/a | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $123 → $116 | $10.73 | n/a | 25 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $207 → $304 | $271.77 | n/a | 17 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 → $10 | $2.07 | n/a | 6 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.000001 | n/a | 9 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $0.0127 | n/a | 4 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $47.67 | n/a | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $54.15 | n/a | 15 | Mar 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $32.12 | n/a | 3 | Mar 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $39.76 | n/a | 6 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $8.65 | n/a | 4 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 → $100 | $5.04 | n/a | 4 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 | $36.36 | n/a | 12 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.28 | n/a | 1 | Apr 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $138.01 | n/a | 3 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.00001 | n/a | 2 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $69 | $46.54 | n/a | 1 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $2.60 | n/a | 5 | Mar 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.90 | n/a | 3 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $10.39 | n/a | 4 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $17 | $0.0003 | n/a | 6 | Feb 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $2.82 | n/a | 5 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $36 | $918.22 | n/a | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $0.0001 | n/a | 4 | Sep 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $1.22 | n/a | 3 | Apr 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $3.34 | n/a | 1 | Mar 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.02 | n/a | 2 | Dec 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.65 | n/a | 4 | Nov 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.81 | n/a | 3 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.81 | n/a | 6 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.03 | n/a | 3 | Nov 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.28 | n/a | 4 | Aug 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.9259 | n/a | 1 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.05 | n/a | 1 | May 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $25.88 | n/a | 1 | Feb 25, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.0001 | n/a | 1 | May 19, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $0.001 | n/a | 1 | Mar 28, 2012 |
Zentalis Pharmaceuticals
Jul 23, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $4.33
Upside: +154.04%
Atossa Therapeutics
Jul 7, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $2.30
Upside: +422.88%
vTv Therapeutics
Jun 30, 2026
Initiated Coverage: Buy
Price Target: $67
Current: $30.73
Upside: +118.03%
Kyntra Bio
Jun 9, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $7.03
Upside: +326.74%
Bolt Biotherapeutics
May 28, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $3.83
Upside: +474.41%
Sana Biotechnology
May 11, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $3.18
Upside: +403.14%
TuHURA Biosciences
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $150 → $7
Current: $2.11
Upside: +231.75%
BioXcel Therapeutics
Mar 17, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $0.8475
Upside: +1,905.90%
Karyopharm Therapeutics
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $22 → $28
Current: $7.41
Upside: +277.87%
Elicio Therapeutics
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $3.00
Upside: +466.67%
Jan 20, 2026
Initiated Coverage: Buy
Price Target: $100
Current: $5.16
Upside: +1,837.98%
Jan 13, 2026
Initiated Coverage: Buy
Price Target: $69 → $17
Current: $0.6884
Upside: +2,369.49%
Jan 13, 2026
Initiated Coverage: Buy
Price Target: $200
Current: $3.37
Upside: +5,834.72%
Jan 13, 2026
Initiated Coverage: Buy
Price Target: $32 → $8
Current: $1.25
Upside: +540.00%
Jan 13, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $0.8818
Upside: +807.24%
Jan 13, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.15
Upside: +595.65%
Jun 26, 2023
Maintained: Buy
Price Target: $11
Current: $2.75
Upside: n/a
May 18, 2023
Reiterated: Buy
Price Target: $6
Current: $5.26
Upside: n/a
May 1, 2023
Reiterated: Buy
Price Target: $862
Current: $656.01
Upside: n/a
Apr 28, 2023
Reiterated: Buy
Price Target: $24
Current: $55.37
Upside: n/a
Apr 27, 2023
Maintained: Buy
Price Target: $10 → $17
Current: $0.0004
Upside: n/a
Apr 26, 2023
Initiated Coverage: Buy
Price Target: $25
Current: $18.21
Upside: n/a
Mar 28, 2023
Reiterated: Buy
Price Target: $8.3
Current: $5.98
Upside: n/a
Mar 24, 2023
Reiterated: Buy
Price Target: $8.3
Current: $0.427
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $42
Current: $19.44
Upside: n/a
Feb 23, 2023
Maintained: Buy
Price Target: $123 → $116
Current: $10.73
Upside: n/a
Feb 21, 2023
Initiated Coverage: Buy
Price Target: $207 → $304
Current: $271.77
Upside: n/a
Dec 16, 2022
Initiated Coverage: Buy
Price Target: $11 → $10
Current: $2.07
Upside: n/a
Mar 30, 2022
Reiterated: Buy
Price Target: $9
Current: $0.000001
Upside: n/a
Mar 29, 2022
Reiterated: Buy
Price Target: $25 → $28
Current: $0.0127
Upside: n/a
Mar 23, 2022
Initiated Coverage: Buy
Price Target: $24
Current: $47.67
Upside: n/a
Mar 22, 2022
Maintained: Buy
Price Target: $46
Current: $54.15
Upside: n/a
Mar 18, 2022
Reiterated: Buy
Price Target: $20
Current: $32.12
Upside: n/a
Mar 16, 2022
Maintained: Buy
Price Target: $31
Current: $39.76
Upside: n/a
Mar 14, 2022
Reiterated: Buy
Price Target: $36
Current: $8.65
Upside: n/a
Mar 11, 2022
Reiterated: Buy
Price Target: $125 → $100
Current: $5.04
Upside: n/a
Mar 3, 2022
Reiterated: Buy
Price Target: $96
Current: $36.36
Upside: n/a
Apr 16, 2018
Reiterated: Buy
Price Target: $11
Current: $2.28
Upside: n/a
Mar 19, 2018
Reiterated: Buy
Price Target: $9
Current: $138.01
Upside: n/a
Mar 8, 2018
Downgraded: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Mar 8, 2018
Initiated Coverage: Buy
Price Target: $69
Current: $46.54
Upside: n/a
Mar 7, 2018
Maintained: Buy
Price Target: $67
Current: $2.60
Upside: n/a
Feb 28, 2018
Downgraded: Hold
Price Target: n/a
Current: $7.90
Upside: n/a
Feb 15, 2018
Reiterated: Buy
Price Target: $24
Current: $10.39
Upside: n/a
Feb 6, 2018
Reiterated: Buy
Price Target: $12 → $17
Current: $0.0003
Upside: n/a
Jan 17, 2018
Reiterated: Buy
Price Target: $3
Current: $2.82
Upside: n/a
Nov 13, 2017
Maintained: Buy
Price Target: $33 → $36
Current: $918.22
Upside: n/a
Sep 28, 2017
Upgraded: Buy
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 26, 2017
Maintained: Buy
Price Target: $21
Current: $1.22
Upside: n/a
Mar 22, 2017
Initiated Coverage: Buy
Price Target: $11
Current: $3.34
Upside: n/a
Dec 14, 2016
Downgraded: Hold
Price Target: n/a
Current: $4.02
Upside: n/a
Nov 21, 2016
Reiterated: Buy
Price Target: n/a
Current: $17.65
Upside: n/a
Nov 11, 2016
Reiterated: Buy
Price Target: n/a
Current: $20.81
Upside: n/a
Nov 10, 2016
Reiterated: Buy
Price Target: n/a
Current: $5.81
Upside: n/a
Nov 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $5.03
Upside: n/a
Aug 18, 2016
Downgraded: Hold
Price Target: n/a
Current: $1.28
Upside: n/a
Aug 8, 2016
Reiterated: Hold
Price Target: n/a
Current: $0.9259
Upside: n/a
May 10, 2016
Reiterated: Hold
Price Target: n/a
Current: $6.05
Upside: n/a
Feb 25, 2015
Reiterated: Hold
Price Target: n/a
Current: $25.88
Upside: n/a
May 19, 2014
Reiterated: Buy
Price Target: $3
Current: $0.0001
Upside: n/a
Mar 28, 2012
Maintained: Buy
Price Target: $24
Current: $0.001
Upside: n/a